Judicious Use of Antimicrobials in the Critical Care Setting

Journal of Infusion Nursing

Volumn 27, Issue 2, 2004, Pages 79-84

  Horner, Megan ^a,b  

^a UNIVERSITY OF GEORGIA   (United States)

^b NORTHSIDE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEPHALOSPORIN; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CLINICAL PROTOCOL; DRUG USE; EMPIRICISM; HOSPITAL; INFECTION; INTENSIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 1642415789     PISSN: 15331458     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129804-200403000-00003     Document Type: Review

References (32)

1. Sing N, Yu VL. Rational empiric antibiotic prescription in the ICU: clinical research is mandatory. Chest. 2000;117(5):1496-1499.
2. DeLisle S, Perl TM. Antimicrobial management measures to limit resistance: a process-based conceptual framework. Crit Care Med. 2001;29(4):N121-N127.
3. Kollef MH. Is there a role for antibiotic cycling in the intensive care unit? Crit Care Med. 2001;29(4):N135-N142.
4. Couper MR. Strategies for the rational use of antimicrobials. Clin Infect Dis. 1997;24(Suppl 1):S154-S156.
5. Ibrahim KH, Gunderson B, Rotschafer JC. Intensive care unit antimicrobial resistance and the role of the pharmacist. Crit Care Med. 2001;29(4):N108-N113.
6. Puzniak LA, Mayfield J, Leet T, et al. Acquisition of vancomycin-resistant enterococci during scheduled antimicrobial rotation in an intensive care unit. Clin Infect Dis. 2001;33:151-157.
7. Dupont H, Mentac H, Sollet JP, et al. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med. 2001;27:355-362.
8. Rello J, Diaz E. Optimal use of antibiotics for intubation-associated pneumonia. Intensive Care Med. 2001;27:337-339.
9. Zimmerman JR. Infectious considerations in the Intensive Care Unit. In: PSAP. Pharmacotherapy Self-Assessment Program. 4th ed. Kansas City: American College of Clinical Pharmacy; 2002.
10. Fridkin SK. Increasing prevalence of antimicrobial resistance in intensive care units. Crit Care Med. 2001;29(4):N64-N68.
11. Warren DK, Fraser VJ. Infection control measures to limit antimicrobial resistance. Crit Care Med. 2001;29(4):N128-N134.
12. Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2001;118(1):146-155.
13. Carmeli Y, Troillet N, Karchmer AW, et al. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med. 1999;159:1127-1132.
14. Rubin RJ, Harrington CA, Poon A, et al. The economic impact of Staphylococcus aureus infection in New York City Hospitals. Emerg Infect Dis. 1999;5:9-17.
15. National Nosocomial Infections Surveillance (NNIS) System. Available at: www.cdc.gov. Accessed January 2003.
16. Goldmann DA, Huskins WC. Control of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide. Clin Infect Dis. 1997;24(Suppl 1):S139-S145.
17. Bailey TC, McMullin T. Using information systems technology to improve antibiotic prescribing. Crit Care Med. 2001;29(4):N87-N91.
18. Kollef MH. Antimicrobial therapy of ventilator-associated pneumonia: how to select an appropriate drug regimen. Chest. 1999;115(1):8-11.
19. Iregui M, Ward S, Sherman G, et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest. 2002;122(1):262-268.
20. Niederman MS. Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit Care Med. 2001;29(4):N114-N120.
21. Raymond DP, Pelletier SJ, Crabtree TD, et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med. 2001;29(6):1101-1108.
22. Kollef MH, Vlasnik J, Sharpless L, et al. Scheduled rotation of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia due to antibiotic resistant gram-negative bacteria. Am J Resp Crit Care Med. 1997;156:1040-1048.
23. Scott G. Prevention and control of infections in intensive care. Intensive Care Med. 2000;26:S22-S25.
24. Meyer KS, Urban C, Eagan JA, et al. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med. 1993;119:353-358.
25. Rahal JJ, Urban C, Horn D, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 1998;1233-1237.
26. Price J, Ekleberry A, Grover A, et al. Evaluation of clinical practice guidelines on outcome of infection in patients in the surgical intensive care unit. Crit Care Med. 1999;27(10):2118-2124.
27. Sing N, Rogers P, Atwood CW, et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med. 2000;162:505-511.
28. Blanc P, Von Elm BE, Geissler A, et al. Economic impact of a rational use of antibiotics in intensive care. Intensive Care Med. 1995;25:1407-1412.
29. De Lalla F. Antibiotic therapy and microbiologic considerations in the intensive care unit. Kidney Int. 1998;53(66):S87-S90.
30. White RL, Friedrich LV, Mihm LB, et al. Assessment of the relationship between antimicrobial usage and susceptibility: differences between the hospital and specific patient care areas. Clin Infect Dis. 2000;31:16-23.
31. Fridkin SK, Steward CD, Edwards JR, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2. Clin Infect Dis. 1999;29:245-252.
32. Schentag JJ. Antimicrobial management strategies for gram-positive bacterial resistance in the intensive care unit. Crit Care Med. 2001;29(4):N100-N107.